Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 672 entries
View as:

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

Phase: N/A Priority: Normal
NCT ID: NCT00647946 Org: User:
Start: 02/28/03 End: 02/28/06 Due: 02/28/07

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Phase: N/A Priority: Normal
NCT ID: NCT04620733 Org: User:
Start: 04/21/21 End: 08/11/23 Due: 08/11/24

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

Phase: N/A Priority: Normal
NCT ID: NCT02533427 Org: User:
Start: 10/29/15 End: 03/18/16 Due: 03/18/17

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003338 Org: User:
Start: 03/31/97 End: - Due: -

Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01072695 Org: User:
Start: 02/28/10 End: 01/31/12 Due: 01/31/13

A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00999531 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT01314716 Org: User:
Start: 04/30/11 End: 07/31/13 Due: 07/31/14

US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05627466 Org: User:
Start: - End: - Due: -

A Study of PMPA in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002180 Org: User:
Start: - End: - Due: -

A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT01841489 Org: User:
Start: 05/31/13 End: 10/31/13 Due: 10/31/14

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00423592 Org: User:
Start: 05/31/05 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion

Phase: N/A Priority: Normal
NCT ID: NCT02044822 Org: User:
Start: 08/06/14 End: 05/17/16 Due: 05/17/17

Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02176876 Org: User:
Start: 08/31/14 End: 06/30/15 Due: 06/30/16

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT04639986 Org: User:
Start: 11/23/20 End: 12/31/25 Due: 12/31/26

Study of GS-0272 in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06031415 Org: User:
Start: 09/28/23 End: 06/30/25 Due: 06/30/26

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02562742 Org: User:
Start: 11/12/15 End: 06/12/17 Due: 06/12/18

Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02002767 Org: User:
Start: 12/16/13 End: 06/09/14 Due: 06/09/15

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02994056 Org: User:
Start: 01/23/17 End: 12/12/18 Due: 12/12/19

Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00650949 Org: User:
Start: 11/30/09 End: 06/30/11 Due: 06/30/12

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02822794 Org: User:
Start: 07/25/16 End: 08/25/17 Due: 08/25/18

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01707472 Org: User:
Start: 10/04/12 End: 10/17/14 Due: 10/17/15

GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02983604 Org: User:
Start: 01/10/17 End: 07/19/18 Due: 07/19/19

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00743795 Org: User:
Start: 10/31/08 End: 09/30/13 Due: 09/30/14

Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02728206 Org: User:
Start: 06/12/16 End: 01/16/18 Due: 01/16/19

Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02177786 Org: User:
Start: 06/30/14 End: 08/31/16 Due: 08/31/17